These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15891407)

  • 1. Clinical trials in multiple sclerosis: methodological issues.
    Comi G; Filippi M
    Curr Opin Neurol; 2005 Jun; 18(3):245-52. PubMed ID: 15891407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin treatment in multiple sclerosis: a systematic review and meta-analysis.
    Pihl-Jensen G; Tsakiri A; Frederiksen JL
    CNS Drugs; 2015 Apr; 29(4):277-91. PubMed ID: 25795002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs.
    Hyland M; Rudick RA
    Curr Opin Neurol; 2011 Jun; 24(3):255-61. PubMed ID: 21455068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approved options for treating patients with multiple sclerosis.
    Rizvi SA; Agius MA
    Neurology; 2004 Dec; 63(12 Suppl 6):S8-14. PubMed ID: 15623672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome Measures in Clinical Trials for Multiple Sclerosis.
    van Munster CE; Uitdehaag BM
    CNS Drugs; 2017 Mar; 31(3):217-236. PubMed ID: 28185158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging multiple sclerosis disease-modifying therapies.
    Giacomini PS; Darlington PJ; Bar-Or A
    Curr Opin Neurol; 2009 Jun; 22(3):226-32. PubMed ID: 19434781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A changing treatment landscape for multiple sclerosis: challenges and opportunities.
    Piehl F
    J Intern Med; 2014 Apr; 275(4):364-81. PubMed ID: 24444084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
    Rieckmann P; Toyka KV; Bassetti C; Beer K; Beer S; Buettner U; Chofflon M; Götschi-Fuchs M; Hess K; Kappos L; Kesselring J; Goebels N; Ludin HP; Mattle H; Schluep M; Vaney C; Baumhackl U; Berger T; Deisenhammer F; Fazekas F; Freimüller M; Kollegger H; Kristoferitsch W; Lassmann H; Markut H; Strasser-Fuchs S; Vass K; Altenkirch H; Bamborschke S; Baum K; Benecke R; Brück W; Dommasch D; Elias WG; Gass A; Gehlen W; Haas J; Haferkamp G; Hanefeld F; Hartung HP; Heesen C; Heidenreich F; Heitmann R; Hemmer B; Hense T; Hohlfeld R; Janzen RW; Japp G; Jung S; Jügelt E; Koehler J; Kölmel W; König N; Lowitzsch K; Manegold U; Melms A; Mertin J; Oschmann P; Petereit HF; Pette M; Pöhlau D; Pohl D; Poser S; Sailer M; Schmidt S; Schock G; Schulz M; Schwarz S; Seidel D; Sommer N; Stangel M; Stark E; Steinbrecher A; Tumani H; Voltz R; Weber F; Weinrich W; Weissert R; Wiendl H; Wiethölter H; Wildemann U; Zettl UK; Zipp F; Zschenderlein R; Izquierdo G; Kirjazovas A; Packauskas L; Miller D; Koncan Vracko B; Millers A; Orologas A; Panellus M; Sindic CJ; Bratic M; Svraka A; Vella NR; Stelmasiak Z; Selmaj K; Bartosik-Psujik H; Mitosek-Szewczyk K; Belniak E; Mochecka A; Bayas A; Chan A; Flachenecker P; Gold R; Kallmann B; Leussink V; Mäurer M; Ruprecht K; Stoll G; Weilbach FX;
    J Neurol; 2004 Nov; 251(11):1329-39. PubMed ID: 15592728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
    Sormani MP; Stubinski B; Cornelisse P; Rocak S; Li D; De Stefano N
    Mult Scler; 2011 May; 17(5):541-9. PubMed ID: 21148262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs.
    Sormani MP; Bonzano L; Roccatagliata L; De Stefano N
    Mult Scler; 2011 May; 17(5):630-3. PubMed ID: 21177320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI in the diagnosis and management of multiple sclerosis.
    Arnold DL; Matthews PM
    Neurology; 2002 Apr; 58(8 Suppl 4):S23-31. PubMed ID: 11971123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
    Nikfar S; Rahimi R; Abdollahi M
    Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI measures of neuroprotection and repair in multiple sclerosis.
    Inglese M
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S16-23. PubMed ID: 22206761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.